<p>The National Cancer Institute awarded a purchase order to Dynamism, Inc. for $6,041.65 on December 14, 2017, with completion scheduled for January 14, 2018. The awardee is a small disadvantaged business. Performance takes place in Bethesda, Maryland. The order is a firm fixed price purchase of advanced manufacturing and printing solutions, including 3D printing technologies and related supplies.</p>
<p>The National Cancer Institute awarded a purchase order to DCM Bioservices LLC for $16,070.00 on July 6, 2017, with an ultimate completion date of August 22, 2018. No set-aside was used. Work is performed in Bethesda, Maryland. The order covers maintenance, repair, and technical support for laboratory automation equipment, including preventive maintenance, emergency repairs, software updates, and support for sophisticated laboratory instruments used in medical research.</p>
<p>The National Cancer Institute awarded a purchase order to Mjmwrite LLC for $8,030.00 on November 1, 2017. Performance is located in Bethesda, Maryland. The order carries a firm fixed price structure and an ultimate completion date of April 30, 2018. No set-aside was applied.</p>
<p>The National Cancer Institute awarded a purchase order to DCM Bioservices LLC for $16,070.00 on August 30, 2018, with completion by August 31, 2019. No set-aside applied. Work is performed at Bethesda, Maryland. The order covers maintenance, repair, and technical support for laboratory automation equipment, including preventive maintenance, emergency repairs, and software updates for sophisticated laboratory instruments used in medical research.</p>
<p>The National Cancer Institute awarded a purchase order to Customarray, Inc. for $10,050.00 on May 3, 2018. Work is performed in Bethesda, Maryland. The order carries no set-aside designation and is priced on a firm fixed price basis, with an ultimate completion date of June 4, 2018.</p>
<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>
<p>The National Cancer Institute awarded a purchase order to Nexome Genomics Inc. for $10,000.00 on July 2, 2018. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Work is scheduled for completion by August 2, 2018.</p>
<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $21,581.00 on August 28, 2018, with completion scheduled for September 28, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>
<p>The National Cancer Institute awarded a purchase order to Noldus Information Technology, Inc. for $14,797.00 on September 8, 2017, with ultimate completion on September 7, 2018. Performance occurs in Bethesda, Maryland. The order is fixed-price with economic price adjustment and carries no small business set-aside. The source does not specify the particular equipment, software, or services procured under this order.</p>
<p>The National Cancer Institute awarded a purchase order to Media Cybernetics Inc., a small disadvantaged business, valued at $14,985.00 on August 14, 2017. Performance is scheduled for completion by September 15, 2018, at Bethesda, Maryland. The order is firm fixed price with no small business set-aside. The source does not specify the particular products or services being procured.</p>